Every 8-K that Remsleep Holding (RMSL) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow RMSL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RMSL filings page.
RemSleep Holdings, Inc. (RMSL) reports that Fruci & Associates II, PLLC resigned as its independent registered public accounting firm effective July 17, 2026. The company states the resignation was amicable and not due to any disagreements over accounting principles, disclosures, or auditing scope or procedures.
RemSleep is in the process of engaging a successor PCAOB-registered firm and plans to announce the appointment and provide additional required disclosures once the engagement is formalized. Current management, which took over during a second-quarter 2026 change in control and leadership transition, is reviewing accounting records and internal financial controls.
In connection with this transition, management has identified issues relating to the recognition, classification, and timing of certain liabilities, indebtedness, and payments affecting second-quarter 2026 information. An additional review of the quarter ended June 30, 2026 will be conducted, which may result in adjustments and could lead to amendments or a restatement if determined appropriate.
RemSleep Holdings, Inc. reported a change in control, major leadership turnover, large equity compensation grants, and a shift in its operating model. Control of the company moved to 1000152403 ONTARIO INC through private, all-cash purchases of preferred shares from existing holders, alongside assumption of approximately $300,000 of issuer and/or preferred shareholder obligations.
Multiple senior officers, including the prior CEO, COO/Chairman, and President/Treasurer/Secretary, resigned effective May 27, 2026. The Board installed a new team: Teresita Rubio as Treasurer and Chairman, Dr. Sanja Pekovic as CEO, Peter Downey as Interim President, and Irina Veselinovic as Secretary, with tight limits placed on the President’s unilateral authority over share issuance and bank accounts.
The Board approved compensatory issuances of 15,000,000 restricted common shares to Scott Hasselbring and 30,000,000 restricted common shares to Roman Israel Wood in lieu of cash. RemSleep closed its Georgia office, relocated operations and a new warehouse to Florida, and is transitioning from a local “cash and carry” model toward internet-focused e-commerce and e-retail channels. The company re-engaged its auditor to complete a late Q1 filing within the available extension period and updated Nevada corporate records to reflect the governance changes.
REMSleep Holdings reports the passing of founder, Chairman, and CEO Thomas Wood on February 26, 2026, shortly after achieving FDA clearance and commercial readiness for its DeltaWave Nasal Pillow System. His death created vacancies in both the CEO and Board chair roles.
Effective March 2, 2026, Anita Michaels, Mr. Wood’s sister and now majority shareholder through inherited super-voting preferred shares, elected herself Chairman and added Jeffrey Marshall and Alexander Johnson as directors. The reconstituted Board unanimously ratified these actions.
Jeffrey Marshall was also appointed Chief Executive Officer under an Executive Employment Agreement providing a base salary and performance-based stock options of up to 7% of fully diluted capitalization, subject to milestones and standard termination and severance terms. Alexander Johnson joins as a director with prior advisory experience to the Company on capital formation and governance.